Background/Aims: At least 300 prenylated proteins are identified in the human genome; the majority of which partake in a variety of cellular processes including growth, differentiation, cytoskeletal organization/dynamics and vesicle trafficking. Aberrant prenylation of proteins is implicated in human pathologies including cancer; neurodegenerative diseases, retinitis pigmentosa, and premature ageing syndromes. Original observations from our laboratory have demonstrated that prenylation of proteins [small G-proteins and γ-subunits of trimeric G-proteins] is requisite for physiological insulin secretion. Herein, we assessed the impact of metabolic stress [gluco-, lipotoxicity and ER-stress] on the functional status of protein prenylation pathway in pancreatic β-cells. Methods: Farnesyltransferase [FTase] and geranylgeranyltransferase [GGTase] activities were quantified by radioisotopic methods. Caspase-3 activation and FTase/GGTase-α subunit degradation were determined by Western blotting. Results: We observed that metabolic stress activates caspase-3 and induces degradation of the common α-subunit of FTase and GGTase-I in INS-1 832/13 cells, normal rodent islets and human islets leading to functional defects [inactivation] in FTase and GGTase activities. Caspase-3 activation and FTase/GGTase-α degradation were also seen in islets from the Zucker diabetic fatty [ZDF] rat, a model for Type 2 diabetes. Consequential to defects in FTase/GGTase-α signaling, we observed significant accumulation of unprenylated proteins [Rap1] in β-cells exposed to glucotoxic conditions. These findings were replicated in β-cells R. Veluthakal, D. K. Arora and M. L. Goalstone contributed equally to this work.
Introduction
A variety of signaling proteins including small molecular mass G-proteins [e.g., Ras, Cdc42 and Rac1], the γ-subunits of hetero-trimeric G-proteins and nuclear lamins [e.g., lamins A and B] undergo a series of post-translational modifications at their C-terminal cysteine residues including prenylation [i.e., farnesylation and geranylgeranylation], carboxylmethylation, and palmitoylation [1] [2] [3] [4] [5] [6] [7] . It has been demonstrated that such modification steps are requisite for the trafficking/targeting of prenylated proteins to appropriate cellular compartments for optimal interaction with, and activation of, their effector proteins leading to cellular activation [1] [2] [3] [4] [5] [6] [7] . Prenylation represents the first modification step in which either a 15-carbon [farnesyl] or a 20-carbon [geranylgeranyl] derivative of mevalonic acid [MVA] is incorporated into candidate proteins (Fig. 1) . The farnesyl transferase [FTase] and the geranylgeranyl transferase-1 [GGTase-1] mediate incorporation of farnesylpyrophosphate [Fpp] and geranylgeranyl-pyrophosphate [GGpp] , respectively. Examples of farnesylated proteins include H-Ras, lamins A and B and geranylgeranylated proteins include small G-proteins such as Cdc42, Rac1, Rho and Rap1 (Fig. 1 ). FTase and GGTases are heterodimeric comprising of a common α-subunit, but distinct β-subunits, and the latter confer the substrate specificity for FTase and GGTases. Using various small molecule inhibitors of FTase and GGTases [GGTI-2147] , or the dominant negative mutant of the FTase/GGTase-α subunit or siRNAs for FTase or GGTase β-subunits, several recent studies have demonstrated novel roles of protein prenylation in glucose-stimulated insulin secretion [GSIS] from clonal β-cells and rodent islets [1, 2, 5, 6, [8] [9] [10] [11] . In addition to GGTase-I, GGpp is utilized by GGTase-II for geranylgeranylation of Rab subfamily of GTPases (Rab3A; Fig. 1 ). Note that α and β subunits of heterodimeric GGTase-II are distinct from their GGTase-I counterparts. Using pharmacological approaches, we have recently reported key roles for GGTase-II [Rab prenylation] in GSIS [12] .
Despite compelling evidence for key regulatory roles of protein farnesylation and geranylgeranylation in islet function, including GSIS, very little is known, however, about the fate of these signaling steps under conditions of metabolic stress in the pancreatic islet β-cell. In the context of prenyltransferase-mediated regulation of cellular function, Kim and associates have reported that the common α-subunit of FTase/GGTase undergoes caspase-3 mediated cleavage into a smaller peptide [~35 kDa] during cell apoptosis [13] . They reported caspase-3 activation and FTase/GGTase α-subunit degradation in a mouse lymphoma W4 cells [expressing the Fas receptor] following exposure to anti-Fas antibodies. They also observed caspase-3 activation and FTase/GGTase α-subunit degradation in Rat-2/H-ras cells treated with an FTase inhibitor [LB42708] or in Rat-1 cells treated with etoposide, a genotoxic agent. These data have led the authors to suggest key roles for caspase-3 mediated degradation of FTase/GGTase α-subunit in cell demise [13] .
More recently, we have assessed the status of FTase/GGTase-α signaling pathway in pancreatic β-cells exposed to etoposide, which induces robust activation of caspase-3 and apoptosis in insulin-secreting INS-1 832/13 cells [14] . We demonstrated a marked increase in caspase-3 activation and FTase/GGTase-α degradation in cells exposed to etoposide. Specificity of caspase-3 in the degradation of FTase/GGTase-α was further confirmed by pharmacological inhibition of caspase-3 [Z-DEVD-FMK], which prevented etoposide-induced degradation of FTase/GGTase-α in INS-1 832/13 cells. Lastly, degradation of FTase/GGTase-α was also seen in these cells exposed to the active fragment [recombinant] of caspase-3. Based on these observations, we concluded that caspase-3 mediates FTase/GGTase-α degradation in pancreatic β-cells under conditions of cellular apoptosis [14] .
The current study is aimed at understanding the functional status of protein prenylation pathway in pancreatic β-cells exposed to a variety of metabolic stress conditions [glucotoxicity, lipotoxicity and ER-stress]. Our findings not only provide the first evidence indicating caspase-3 activation and FTase/GGTase-α degradation; they also demonstrate significant attenuation of FTase and GGTase activities resulting in accumulation of unprenylated proteins. The membranes were washed 5 times for 5 min each with TBS-T and probed with appropriate horseradish peroxidase-conjugated secondary antibodies in 5% non-fat dry milk in TBS-T at room temperature for 1 h. After washing, the immune complexes comprising of the target proteins were detected using the ECL kit. The membranes then were stripped and reprobed with β-actin. The band intensity was quantified and protein expression levels were calculated relative to β-actin in the same sample.
Materials and Methods

Materials
FTase and GGTase Assays
These assays were performed using a modified method as we described in [16] . 
Statistical analysis
Results are expressed as means with their standard errors as indicated. Data are analyzed using one way ANOVA followed by Bonferroni posthoc test [GraphPad Prism 5; GraphPad Software, Inc., La Jolla, CA, USA]. Differences between control and treatment groups were considered significant if p is < 0.05.
Results
Using pharmacological and molecular biological approaches, we have previously demonstrated requisite roles for protein farnesylation and geranylgeranylation in GSIS in INS-1 832/13 β-cells and normal rodent islets [1, 2, 5, 6, [8] [9] [10] [11] . Key findings were also confirmed in islets from normal human donors. However, significant gaps still exist in our current understanding about the metabolic fate of these pathways under the duress of metabolic stress, including glucotoxicity, lipotoxicity and ER stress in the islet β-cell [6, 15, 18, 19] . Therefore, we undertook the current investigation to assess the functional status of FTase/GGTase-α signaling mechanisms in INS-1 832/13 cells, normal rodent and human islets exposed to gluco-, lipotoxic and ER stress conditions. Together, these data demonstrate activation of caspase-3 and degradation of FTase/GGTase-α in INS-1 832/13 cells, rat islets and human islets exposed to a wide variety of metabolic stress conditions. Lastly, such metabolic defects were also demonstrable in islets from the ZDF rat.
Metabolic stress conditions activate caspase-3 and induce degradation of FTase/GGTase-α in a variety of insulin secreting cells
Metabolic stress conditions induce defects in FTase and GGTase activities in INS-1 832/13 cells
We next examined consequences of FTase/GGTase-α degradation on the catalytic activities of FTase and GGTase-I in INS-1 832/13 cells exposed to glucotoxic, lipotoxic and 
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ER stress conditions. Data shown in Fig. 3 demonstrate a significant reduction in both FTase and GGTase activities under conditions in which the FTase/GGTase-α is degraded (Fig. 2) . We recently determined the specificity of caspase-3 mediated degradation of FTase/GGTase-α using specific inhibitor of caspase-3 and recombinant biologically-active caspase-3 [14] . Based on these data we conclude that metabolic stress conditions promote activation of caspase-3 leading to degradation of FTase/GGTase-α culminating in the catalytic inactivation of FTase and GGTase.
Inhibition of protein prenyltransferases results in accumulation of unprenylated proteins in INS-1 832/13 cells and normal rat islets
As a logical extension to the above studies, we asked if functional inactivation of prenyltransferases results in accumulation of unprenylated G-proteins in pancreatic β-cells exposed to glucotoxic conditions. In these studies we also examined the effects of Simvastatin, a known inhibitor of HMG-CoA reductase pathway, which depletes intracellular pools of MVA and its downstream metabolites [Fpp and GGpp], which are required for protein prenylation by FTase and GGTase (Fig. 1) . In order to identify the abundance of unprenylated proteins, we used an antiserum directed against unprenylated Rap1, which is prenylated by GGTase-I (Fig. 1) . Data in Fig. 4 
Discussion
Emerging evidence from multiple laboratories suggests requisite regulatory roles for protein prenylation in a variety of cellular processes including growth, differentiation, cytoskeletal organization and dynamics and vesicle trafficking [3] [4] [5] [6] [7] . It is also becoming increasingly clear that alterations in prenylation of proteins [Ras, nuclear lamins] lead to human pathologies including cancer; neurodegenerative diseases, retinitis pigmentosa, and premature ageing syndromes [20] [21] [22] [23] . The overall objective of our study was to assess the functional status of protein prenylation signaling in pancreatic β-cells exposed to metabolic stress conditions. In these studies, we employed INS-1 832/13 cells, normal rat islets, human islets and islets from the ZDF rat, a model for Type 2 diabetes. We demonstrated that metabolic stress activates caspase-3 and induces degradation of FTase/GGTase-α in a variety of insulin secreting cells leading to functional defects [inactivation] in FTase and GGTase activities. We also observed that, in a manner akin to the effects seen under glucotoxic conditions, inhibition of intracellular generation of Fpp or GGpp (with Simvastatin; Fig.  1 ) as well as inhibition of GGTase-I activity (GGTI-2147; Fig. 1 ) results in accumulation of unprenylated G-proteins. In support of our current findings and conclusions, are earlier studies, which demonstrated significant reduction in GSIS in insulin-secreting cells exposed to HG or Simvastatin [1, [24] [25] [26] [27] [28] [29] . Together, our findings suggest that islet β-cell dysfunction [e.g., loss in GSIS] under metabolic stress conditions may, in part, be due to defects in the protein prenylation signaling that we demonstrated in the current study.
The current studies provide the first evidence to suggest significant defects in FTase and GGTase activities in pancreatic β-cells following exposure to gluco-, lipotoxic and ER stress conditions. We propose that it is consequential to the degradation of the FTase/GGTase-α subunit under these conditions. Cleavage of FTase/GGTase-α subunit could result in the defects in the formation of the heterodimer [αβ subunit complex] of the enzyme leading to its functional inactivation. It should be noted that the α-subunit of FTase/GGTase is considered the regulatory subunit while the β subunit contains the catalytic active site. Interestingly, the β subunit is functionally inactive without α subunit suggesting that the heterodimeric "holoenzyme" conformation is necessary for the catalytic function of the enzyme. Veluthakal 
Cellular Physiology and Biochemistry
What then are potential functional consequences of impaired prenylation of proteins? Recently Khan et al. have reported hyperactivation of macrophages and associated induction of erosive arthritis in mice lacking GGTase-I [30] , thus raising potential for regulatory roles of geranylgeranylation in inflammatory cell signaling [30, 31] . Interestingly, high levels of active [GTP-bound] Rac1, Cdc42 and RhoA were seen in GGTase-deficient cells suggesting potential alternate mechanisms for the activation of these unprenylated G-proteins. They also reported activation of p38 and NF-κB and enhanced production of proinflammatory cytokines consequential to GGTase-I deficiency [30] . Along these lines, studies by Dunford and associates have suggested that inhibition of protein prenylation by nitrogen-containing bisphosphonates caused paradoxical and sustained activation of Rac, Cdc42 and Rho G-proteins in J774 macrophages [32] . Compatible with these findings is recently published evidence from our laboratory suggesting sustained activation of Rac1, a geranylgeranylated protein, in β-cell models of glucolipotoxicity, ER stress and diabetes [6, 15, 17, 19, 33] . We also observed hyperactivation of Rac1 in human islets exposed to glucotoxic conditions and in islets derived from the ZDF rat [15] . These findings have led us to propose that Rac1 plays both positive and negative modulatory roles in the regulation of β-cell function in the sense that while it is critical for GSIS, Rac1 also exerts damaging roles under pathological conditions by inducing Nox2 activity to create excessive oxidative stress, mitochondrial damage and cell demise [15, 26, 34] . It is noteworthy that, recent studies from our laboratories have demonstrated sustained activation of Rac1 in retina from animal models of diabetes [35] , thus suggesting systemic effects of diabetic conditions in the sustained activation of Rac1 and associated increase in Nox2-derived oxidative stress leading to cell dysregulation in target tissues. Together, these findings demonstrate constitutive activation of specific G-proteins under various pathological conditions in the absence of requisite prenylation. Future studies will need to identify the "prenylation-independent" regulatory mechanisms that underlie G-protein activation and potential alterations in their subcellular trafficking [mis-targeting] of these proteins, if any, under the conditions of metabolic stress.
Recent studies have also demonstrated roles of protein prenylation mediated by FTase, GGTase-I and GGTase-II in islet β-cell function including GSIS [5, 6, [10] [11] [12] . Even though our current findings suggest significant defects in islet β-cell induced by metabolic stress, Based on the data accrued in the current investigation and published evidence in the literature, we propose that glucotoxic, lipotoxic or ER-stress conditions induce mitochondrial dysregulation of the islet β-cell leading to caspase-3 activation. Some of these underlying mechanisms could include generation of excessive reactive oxygen species [oxidative stress] mediated by phagocyte-like NADPH oxidase [Nox2], which, in turn, leads to activation of stress kinases [p38MAPK; JNK1/2] and downstream signaling steps [6, 15, 17, 26] . Activated caspase-3 facilitates cleavage of the FTase/GGTase α-subunit culminating in defective prenylation and accumulation of unprenylated G-proteins. Potential regulatory roles of unprenylated proteins in the onset of islet dysfunction remains to be investigated. Further, studies along the lines to address the regulatory roles of the "degraded fragment" of FTase/ GGTase-α in the induction of defective insulin secretion and loss in β-cell survival should yield novel insights into mechanisms underlying islet dysfunction under metabolic stress and diabetes.
specifically at the level of degradation of the regulatory FTase/GGTase-α subunit, it is likely that defects in protein prenylation might be occurring at other "arms" of the protein prenylation pathway (Fig. 1) . In this context, elegant studies by Jiang and associates [36] demonstrated requisite roles for granylgeranyl pyrophosphate synthase [GGPPS] in islet function in health and diabetes. This enzyme is responsible for intracellular generation of GGpp (Fig. 1) . Using a variety of in vitro and in vivo approaches, these researchers demonstrated critical roles for GGPPS in islet β-cell function during the onset of diabetes. Functional activation of GGPPS in islets from db/db mice is increased during the initial compensatory period, followed by a sharp decline during the onset of insulin secretory abnormality. Furthermore, conditional deletion of GGPPS in the islet β-cell resulted in depletion of intracellular GGpp and membrane targeting of Rab27A, and reduced the number of insulin granules in the proximity of the plasma membrane. These data suggest significant defects in granule docking in GGPPS-null mice, leading to decreased GSIS. As highlighted recently in [37] , it is expected that the studies by Jiang et al. [36] will form the basis for future investigations in the field, which might fill the knowledge gaps in our current understanding of the regulatory roles of G-proteins in islet biology in health and diabetes.
Based on the data accrued from our current study, we propose a model for induction of defects in the protein prenylation pathway in islet β-cells exposed to metabolic stress (Fig.  5) . Metabolic stress induces mitochondrial dysregulation and caspase activation; such effects may, in part, be due to increased Nox2-mediated oxidative stress as we reported recently in [15] . Caspase-3 activation leads to cleavage of the regulatory α-subunit of FTase/GGTase resulting in functional inactivation of FTase and GGTase and consequential accumulation of unprenylated proteins. We have demonstrated sustained activation of Rac1 [6, 15, 17, 33] , stress kinase [p38MAPK, JNK1/2; ref. 15, 26] and loss in GSIS [24] [25] [26] under these conditions in a variety of insulin-secreting cells. Additional studies are needed to further assess the functional status of other G-proteins, which have been implicated in islet survival and function, including GSIS. These investigations are underway in our laboratories currently.
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